We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Diagnoses Lung Diseases from Ultrasound Videos with 96.57% Accuracy

By MedImaging International staff writers
Posted on 03 Feb 2025
Image: Heatmaps the AI assessed to make lung disease diagnoses (Photo courtesy of COVIDx-US)
Image: Heatmaps the AI assessed to make lung disease diagnoses (Photo courtesy of COVIDx-US)

Artificial Intelligence (AI) has the potential to become a crucial tool for radiologists, with recent advancements enabling it to accurately diagnose pneumonia, COVID-19, and other lung diseases.

The new study by researchers from Charles Darwin University (CDU, Casuarina, Australia) and other collaborating institutions aims to enhance AI's diagnostic capabilities by training it to analyze lung ultrasound videos for signs of respiratory diseases. The AI model works by examining each individual frame of the ultrasound video to identify key features of the lungs. It also analyzes the sequence of video frames to detect patterns in the lungs' behavior over time. Using this data, the model can pinpoint specific patterns indicative of various lung conditions, categorizing the ultrasound as normal, or as showing signs of pneumonia, COVID-19, or other lung diseases. In addition, the model employs AI techniques to provide explanations for its diagnostic decisions, helping radiologists understand and trust its results. The model utilizes explainable AI, a technique that makes the outputs of machine learning algorithms more transparent to users. By using visual aids like heatmaps, the system helps doctors understand why certain conclusions were made, making it easier for them to localize areas of concern and significantly improving clinical transparency.

This interpretability aims to enhance the reliability of the AI system, making it a useful tool for physicians. Not only can the model help doctors quickly and accurately diagnose lung diseases, but it also supports their decision-making process, saves valuable time, and serves as an educational resource. The findings, published in Frontiers in Computer Science, demonstrate that the model achieved an accuracy rate of 96.57%, with its analyses verified by medical professionals. The researchers believe that with proper training and data, the model could be expanded to detect additional diseases such as tuberculosis, black lung disease, asthma, cancer, chronic lung disease, and pulmonary fibrosis. Future research could involve training the AI model to assess other types of medical imaging, including CT scans and X-rays.

Related Links:
Charles Darwin University 

Post-Processing Imaging System
DynaCAD Prostate
Digital Radiography System
DR-300
Ultrasonic Pocket Doppler
SD1
X-Ray Illuminator
X-Ray Viewbox Illuminators

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.